Showing results (111-120 of 136) with videos related to

Sort By:
Pageof 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
High-Dose celecoxib and metronomic "low-dose" cyclophosphamide is an effective and safe therapy in patients with relapsed and refractory aggressive histology non-Hodgkin's lymphomaRena Buckstein, Robert S Kerbel, Yuval Shaked, et al.
Nature Communications|April 25, 2026
Aged differentiated cells reverse into native stemness-like state by niche cytokines to sustain lifelong homeostasis and tissue repairShalini Dimri-Wagh, Swarnabh Bhattacharya, Gharam Yassen, et al.
Cancer Research|October 20, 2021
T Cells Promote Metastasis by Regulating Extracellular Matrix Remodeling following ChemotherapyJozafina Haj-Shomaly, Avital Vorontsova, Tamar Barenholz-Cohen, et al.
Oncogene|August 31, 2019
Microparticles from tumors exposed to radiation promote immune evasion in part by PD-L1Michael Timaner, Ruslana Kotsofruk, Ziv Raviv, et al.
Molecular Cancer Research : MCR|August 15, 2019
Proinflammatory Macrophages Promote Multiple Myeloma Resistance to Bortezomib TherapyOfrat Beyar-Katz, Ksenia Magidey, Anat Reiner-Benaim, et al.
Leukemia Research|May 14, 2014
Lenalidomide and metronomic melphalan for CMML and higher risk MDS: a phase 2 clinical study with biomarkers of angiogenesisRena Buckstein, Robert Kerbel, Matthew Cheung, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|June 14, 2020
Significance of host heparanase in promoting tumor growth and metastasisGan-Lin Zhang, Lilach Gutter-Kapon, Neta Ilan, et al.
Cell Death & Disease|September 24, 2022
RNF4~RGMb~BMP6 axis required for osteogenic differentiation and cancer cell survivalRostislav Novak, Yamen Abu Ahmad, Michael Timaner, et al.
Pageof 14